The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200.
Intercontinental Exchange
ICE · a US exchange · USD · Market cap $88.6B · 12,694 employees
Intercontinental Exchange, Inc., together with its subsidiaries, provides technology and data to financial institutions, corporations, and government entities in the United States, the United Kingdom, the European Union,…
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Intercontinental Exchange holds its Distribution at $157.76. Consolidating, no directional conviction, held for 2 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 2 days |
| Price at the screen | $157.76 |
| Valuation | 22.22 trailing · 17.93 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.93 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $157.01 fair value estimate, moderate competitive moat, 4.80% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. The price runs 0.5% above the base estimate.
Third-party analyst targets: 14 covering, consensus Strong Buy. The average target sits +15% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsThe Quiet Engine Behind Global Trading Floors
Every futures contract or equity trade that clears in New York or London runs across pipes built by a handful of exchange groups. Intercontinental Exchange sits at the centre of that network, posting 20% revenue growth, 38% profit margins and a 14% return on equity while the market prices it at 16 times forward earnings with an 11% margin of safety to our fair value.
We pass for one reason that has nothing to do with the numbers. The business fails our ethical screen on activity grounds. This is exactly what the screen is for.
The moderate moat and strong buy analyst chorus do not change the outcome. Analysis, not advice.
| Forward P/E | 17.9xexpensive even after accounting for its growth |
| Trailing P/E | 22.2xa premium valuation |
| EPS, trailing | 7.10 |
| EPS, forward | 8.80 |
| Revenue growth | +4.8%slow but positive growth |
| Profit margin | 38.2%highly profitable on every dollar of sales |
| Return on equity | 14.1%a solid return on shareholder capital |
| FCF yield | 4.10% |
| Dividend yield | 133.00% |
| Debt to equity | 0.69moderate, manageable leverage |
| Current ratio | 1.01adequate liquidity, worth monitoring |
| Beta | 0.93steadier than the market |
| Short interest, float | 0.02% |
| 52-week range | 121.79 - 176.59 |
| Moat | MODERATE |
| Market cap | $88.6B |
| Employees | 12,694 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeICE trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 19%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (15 analysts) rates it strong buy, with a mean price target of $200.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Financial Exchanges & Data Stocks Q1 Highlights: Intercontinental Exchange (NYSE:ICE) StockStory · 17 Jul 2026
- Intercontinental Exchange (ICE) Hits Record Natural Gas Open Interest As LNG Demand Grows Simply Wall St. · 17 Jul 2026
- Intercontinental Exchange (ICE) Stock Fair Value Edges Lower As Analysts Trim Targets Simply Wall St. · 17 Jul 2026
- Investors’ Concerns About Regulatory Changes Hurt Intercontinental Exchange (ICE) Insider Monkey · 16 Jul 2026
- Does Intercontinental Exchange (ICE) Have a Positive Outlook Amid Challenges? Insider Monkey · 16 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | GARDINER WARREN | Chief Financial Officer | 2,490 | $390,034 | |
| 2026-05-18 | HAGUE WILLIAM JEFFERSON | Director | 1,538 | · | |
| 2026-05-18 | SILVER CAROLINE LOUISE | Director | 1,698 | · | |
| 2026-05-18 | TIRINNANZI MARTHA A | Director | 1,698 | · | |
| 2026-05-18 | COOPER SHANTELLA E | Director | 1,538 | · | |
| 2026-05-18 | FAROOQUI DURIYA M | Director | 1,538 | · | |
| 2026-05-18 | BOWEN SHARON J.D. | Director | 1,538 | · | |
| 2026-05-18 | HILL JONATHAN HOPKIN | Director | 1,698 | · | |
| 2026-05-14 | KAPANI MAYUR | Chief Technology Officer | 4,271 | $663,797 | |
| 2026-05-14 | KAPANI MAYUR | Chief Technology Officer | 4,271 | $286,157 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Jun2026 | Tony Wied | Republican | buy | 15K–50K |
| 9 Jun2026 | Tony Wied | Republican | sell | 100K–250K |
| 8 Jul2026 | April McClain Delaney | Democrat | sell | 1K–15K |
| 8 Dec2025 | Julie Johnson | Democrat | buy | 1K–15K |
| 8 Dec2025 | Julie Johnson | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $157.82 | -11.2% | · | $889 | -11.2% |
| 2 months | $160.60 | -12.7% | · | $873 | -12.7% |
| 3 months | $158.10 | -11.3% | $0.52 | $890 | -11.0% |
| 6 months | $162.09 | -13.5% | $1.00 | $871 | -12.9% |
| 1 year | $173.49 | -19.2% | $1.96 | $819 | -18.1% |
| 2 years | $130.77 | +7.2% | $3.79 | $1,101 | +10.1% |
| 3 years | $105.88 | +32.4% | $5.50 | $1,376 | +37.6% |
| 5 years | $105.63 | +32.7% | $8.43 | $1,407 | +40.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ICE does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.